Dr. Kittai is a clinical assistant professor in the Division of Hematology at The Ohio State University in Columbus, Ohio. He is a clinical investigator with a focus on chronic lymphocytic leukemia and Richter’s Syndrome, specifically developing clinical trials for patients with these diseases. Dr. Kittai’s research focus is on bringing cellular therapies to patients with high-risk disease. Furthermore, Dr. Kittai is exploring what prognostic features of chronic lymphocytic leukemia are still relevant in the era of targeted therapies.